Exam aid · Exam-specific: DRAP and PFSA
DRAP & Regulatory Affairs
Who decides what, which law covers which product, and the international codes DRAP officer and Drug Inspector papers ask about.
Tables to memorise
Cover the right-hand column and test yourself before checking.
Pakistan's pharmacy laws
| Law / rules | Covers |
|---|---|
| Pharmacy Act 1967 | Pharmacy councils, education, registration of pharmacists |
| Drugs Act 1976 | Import, manufacture, sale, quality offences, inspectors, Drug Courts |
| Control of Narcotic Substances Act 1997 | Narcotics, psychotropics, precursors |
| DRAP Act 2012 | Establishes DRAP, the federal therapeutic goods regulator |
| Alternative Medicines and Health Products Rules 2014 | Enlistment of herbal, Unani, homeopathic, nutraceuticals |
| Medical Devices Rules 2017 | Device classification, licensing, registration |
| Bio-Study Rules 2017 | Clinical trials and bioequivalence studies |
| Pharmacovigilance Rules 2022 | ADR reporting and MAH safety duties |
Who decides what
| Body | Decides |
|---|---|
| DRAP Policy Board | Oversight and policy of the Authority |
| Registration Board | Registration of drugs |
| Central Licensing Board | Manufacturing licences |
| Appellate Board | Appeals against board decisions |
| Drug Pricing Committee | Price recommendations (notified by federal government) |
| Provincial Quality Control Board | Prosecution of provincial cases |
| Drug Court | Trials of offences under the Drugs Act |
| Provincial licensing authority | Retail and wholesale sale licences |
| Pharmacy councils | Registration of pharmacists and technicians |
Drug quality definitions (Drugs Act)
| Term | Key idea |
|---|---|
| Spurious | Imitation or substitute; false name or maker |
| Misbranded | False, misleading or improper labelling |
| Adulterated | Filthy, decomposed or made in insanitary conditions |
| Substandard | Fails claimed strength, quality or purity |
| Counterfeit | Deliberately false identity or source |
Pharmacovigilance essentials
| Item | Fact |
|---|---|
| Serious ADR | Death, life-threatening, hospitalisation, disability, congenital anomaly |
| Expedited report | 15 calendar days (serious, unexpected) |
| Causality (WHO-UMC) | Certain, probable, possible, unlikely, conditional, unassessable |
| Periodic report | PBRER (ICH E2C) |
| Case report format | ICSR (ICH E2B) |
| Terminology | MedDRA |
| Global database | VigiBase (Uppsala Monitoring Centre) |
One-liners examiners love
- Registration is federal (DRAP); retail licensing is provincial.
- Drug registration is valid for five years and must be renewed.
- Federal inspectors deal with manufacturers and importers; provincial inspectors with retail and wholesale.
- DRAP's National Control Laboratory for Biologicals releases each vaccine lot.
- CTD Module 3 = quality, 4 = non-clinical, 5 = clinical; Module 1 is regional.
- Medical device classes run from A (lowest risk) to D (highest).
Memory aids
- SMAS-C quality offences
- Spurious, Misbranded, Adulterated, Substandard, Counterfeit.
- R-C-A boards
- Registration Board registers, Central Licensing Board licenses, Appellate Board hears appeals.
Now turn it into marks
Attempt MCQs on these topics while the sheet is fresh. Anything you get wrong goes to your incorrect list for the next round.
Most useful for
More cheat sheets
- Drug Name Stems
- Drugs of Choice
- Signature Adverse Effects
- Enzyme Inducers & Inhibitors
- Drug Sources
- Forensic Toxicology & Narcotics
- Antidotes & Poisons
- Prescription Abbreviations
- Microbiology & Vaccines
- Vitamins & Deficiencies
- PK & Calculation Formulas
- Normal Lab Values
- Therapeutic Ranges & Targets
- QC Tests & Pharmacopoeial Limits
- Biostatistics & Epidemiology
- Gulf Exam Clinical Essentials
- Gulf Licensing Pathway